Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001192482-20-000484

Chief Scientific Officer bought 1,799 shares at $2.28 ($4,098)

From the SEC's structured data for this filing

Trades in this filing

NEIL GARRY ARTHUR · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-06-10 Purchase : show line 1 in the form +1,799 $2.28 $4,098 74,081 D
Open-market purchases · 1,799 sh · avg $2.28 · $4,098
Loading xslF345X03/edgar.xml…